Notably, HDP-101 impacted CD138-positive but not-negative primary cells, showed potent efficacy against aldehyde dehydrogenase-positive clonogenic cells, and eradicated myeloma in an <i>in vivo</i> cell line-derived xenograft (CDX). The gene discussed is SDC1; the disease is plasma cell myeloma.